annual CFF:
$250.88M+$157.66M(+169.11%)Summary
- As of today (August 31, 2025), VRNA annual cash flow from financing activities is $250.88 million, with the most recent change of +$157.66 million (+169.11%) on December 31, 2024.
- During the last 3 years, VRNA annual CFF has risen by +$257.00 million (+4201.90%).
- VRNA annual CFF is now at all-time high.
Performance
VRNA Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$5.05M-$8.46M(-62.62%)Summary
- As of today (August 31, 2025), VRNA quarterly cash flow from financing activities is $5.05 million, with the most recent change of -$8.46 million (-62.62%) on June 1, 2025.
- Over the past year, VRNA quarterly CFF has dropped by -$161.47 million (-96.97%).
- VRNA quarterly CFF is now -97.33% below its all-time high of $189.18 million, reached on September 30, 2020.
Performance
VRNA quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$105.68M-$161.47M(-60.44%)Summary
- As of today (August 31, 2025), VRNA TTM cash flow from financing activities is $105.68 million, with the most recent change of -$161.47 million (-60.44%) on June 1, 2025.
- Over the past year, VRNA TTM CFF has dropped by -$82.06 million (-43.71%).
- VRNA TTM CFF is now -60.44% below its all-time high of $267.15 million, reached on March 31, 2025.
Performance
VRNA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VRNA Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +169.1% | -97.0% | -43.7% |
| 3 y3 years | +4201.9% | +837.6% | +2664.4% |
| 5 y5 years | +100.0% | +100.0% | +10000.0% |
VRNA Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4201.9% | -97.0% | +178.5% | -60.4% | +2664.4% |
| 5 y | 5-year | at high | +4201.9% | -97.3% | +178.5% | -60.4% | +1645.5% |
| alltime | all time | at high | +4201.9% | -97.3% | +178.5% | -60.4% | +1645.5% |
VRNA Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $5.05M(-62.6%) | $105.68M(-60.4%) |
| Mar 2025 | - | $13.51M(-85.6%) | $267.15M(+6.5%) |
| Dec 2024 | $250.88M(+169.1%) | $93.56M(-1554.1%) | $250.88M(+38.3%) |
| Sep 2024 | - | -$6.43M(-103.9%) | $181.39M(-3.4%) |
| Jun 2024 | - | $166.52M(-6138.9%) | $187.74M(+787.1%) |
| Mar 2024 | - | -$2.76M(-111.5%) | $21.16M(-77.3%) |
| Dec 2023 | $93.23M(-33.8%) | $24.07M(<-9900.0%) | $93.23M(+27.5%) |
| Sep 2023 | - | -$83.40K(+30.9%) | $73.11M(-65.4%) |
| Jun 2023 | - | -$63.70K(-100.1%) | $211.38M(+0.3%) |
| Mar 2023 | - | $69.31M(+1655.3%) | $210.76M(+49.8%) |
| Dec 2022 | $140.73M(-2400.9%) | $3.95M(-97.1%) | $140.73M(+3.6%) |
| Sep 2022 | - | $138.19M(<-9900.0%) | $135.89M(-3397.4%) |
| Jun 2022 | - | -$684.60K(-5.2%) | -$4.12M(-39.7%) |
| Mar 2022 | - | -$721.80K(-18.7%) | -$6.84M(+11.8%) |
| Dec 2021 | -$6.12M(-103.2%) | -$888.30K(-51.4%) | -$6.12M(+17.0%) |
| Sep 2021 | - | -$1.83M(-46.3%) | -$5.23M(-102.8%) |
| Jun 2021 | - | -$3.40M(<-9900.0%) | $185.78M(-1.8%) |
| Mar 2021 | - | $0.00(-100.0%) | $189.18M(+0.1%) |
| Dec 2020 | $193.84M(>+9900.0%) | - | - |
| Sep 2020 | - | $189.18M(>+9900.0%) | $189.02M(<-9900.0%) |
| Jun 2020 | - | $0.00(0.0%) | -$319.30K(-25.6%) |
| Mar 2020 | - | $0.00(-100.0%) | -$429.00K(-20.3%) |
| Dec 2019 | $0.00 | -$159.10K(-0.7%) | -$538.40K(+41.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$160.20K(+46.0%) | -$379.30K(+73.1%) |
| Jun 2019 | - | -$109.70K(+0.3%) | -$219.10K(+100.3%) |
| Mar 2019 | - | -$109.40K(<-9900.0%) | -$109.40K(<-9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $0.00(0.0%) | $292.90K(-76.5%) |
| Jun 2018 | - | $0.00(0.0%) | $1.25M(-98.5%) |
| Mar 2018 | - | $0.00(-100.0%) | $85.22M(+1.6%) |
| Dec 2017 | $81.45M(+46.5%) | $292.90K(-69.2%) | $83.90M(+0.4%) |
| Sep 2017 | - | $952.10K(-98.9%) | $83.60M(+1.2%) |
| Jun 2017 | - | $83.97M(-6455.3%) | $82.65M(-6355.3%) |
| Mar 2017 | - | -$1.32M | -$1.32M |
| Dec 2016 | $55.60M(>+9900.0%) | - | - |
| Dec 2015 | $0.00(-100.0%) | - | - |
| Dec 2014 | $21.57M(+664.2%) | - | - |
| Dec 2013 | $2.82M(+74.7%) | - | - |
| Dec 2012 | $1.62M(-52.7%) | - | - |
| Dec 2011 | $3.42M(+153.2%) | - | - |
| Dec 2010 | $1.35M(-57.2%) | - | - |
| Dec 2009 | $3.15M(-29.7%) | - | - |
| Dec 2008 | $4.49M(>+9900.0%) | - | - |
| Dec 2007 | $0.00(-100.0%) | - | - |
| Dec 2006 | $3.17M(+83.3%) | - | - |
| Dec 2005 | $1.73M | - | - |
FAQ
- What is Verona Pharma plc annual cash flow from financing activities?
- What is the all time high annual CFF for Verona Pharma plc?
- What is Verona Pharma plc annual CFF year-on-year change?
- What is Verona Pharma plc quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Verona Pharma plc?
- What is Verona Pharma plc quarterly CFF year-on-year change?
- What is Verona Pharma plc TTM cash flow from financing activities?
- What is the all time high TTM CFF for Verona Pharma plc?
- What is Verona Pharma plc TTM CFF year-on-year change?
What is Verona Pharma plc annual cash flow from financing activities?
The current annual CFF of VRNA is $250.88M
What is the all time high annual CFF for Verona Pharma plc?
Verona Pharma plc all-time high annual cash flow from financing activities is $250.88M
What is Verona Pharma plc annual CFF year-on-year change?
Over the past year, VRNA annual cash flow from financing activities has changed by +$157.66M (+169.11%)
What is Verona Pharma plc quarterly cash flow from financing activities?
The current quarterly CFF of VRNA is $5.05M
What is the all time high quarterly CFF for Verona Pharma plc?
Verona Pharma plc all-time high quarterly cash flow from financing activities is $189.18M
What is Verona Pharma plc quarterly CFF year-on-year change?
Over the past year, VRNA quarterly cash flow from financing activities has changed by -$161.47M (-96.97%)
What is Verona Pharma plc TTM cash flow from financing activities?
The current TTM CFF of VRNA is $105.68M
What is the all time high TTM CFF for Verona Pharma plc?
Verona Pharma plc all-time high TTM cash flow from financing activities is $267.15M
What is Verona Pharma plc TTM CFF year-on-year change?
Over the past year, VRNA TTM cash flow from financing activities has changed by -$82.06M (-43.71%)